Immunovant, Inc. (NASDAQ:IMVT) Short Interest Up 41.1% in March

Retrieved on: 2021-04-18 12:56:15

Tags for this article:

Financial markets

Finance

Charles Schwab Corporation

Investment management

Initial public offering

Immunovant Inc.

Click the tags to see associated articles and topics

Immunovant, Inc. (NASDAQ:IMVT) Short Interest Up 41.1% in March. View article details on hiswai:

Excerpt

It develops IMVT-1401, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, ...

Article found on: www.marketbeat.com

View Original Article